Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease for which a precise
cause has not yet been identified. Standard CT or MRI evaluation does not demonstrate …

Introduction. Despite the rapid development of neuroimaging techniques, the diagnosis of
amyotrophic lateral sclerosis (ALS) remains a significant challenge. Magnetic resonance …

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease, characterized by
progressive loss of motor function. While the pathogenesis of ALS remains largely unknown …

Advanced magnetic resonance imaging (MRI) techniques hold the promise to capture upper
motor neuron loss and extramotor brain changes in amyotrophic lateral sclerosis (ALS) and …

This work evaluates the potential in diagnostic application of a new advanced neuroimaging
method, which delineates the profile of tissue properties along the corticospinal tract (CST) …

Traumatic brain injury (TBI) has been suggested to increase the risk of amyotrophic lateral
sclerosis (ALS). However, this link remains controversial and as such, here we performed …

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease. However, no reliable
biomarkers have been identified to represent the clinical status. This study aimed to …

Background and purpose Magnetic resonance diffusivity indices have been repeatedly
proposed as biomarkers of neurodegeneration in amyotrophic lateral sclerosis (ALS), but no …

ABSTRACT PURPOSE The purpose of the present retrospective study was to evaluate the
sensitivity of susceptibility‐weighted imaging (SWI) compared to conventional spin‐echo T2 …

Amyotrophic lateral sclerosis (ALS) and behavioral variant frontotemporal dementia (bvFTD)
lie on a clinical, pathologic, and genetic continuum. Neuroimaging techniques have proven …